SCHIZOAFFECTIVE DISORDER
Clinical trials for SCHIZOAFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZOAFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZOAFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eye test may predict schizophrenia treatment success, but study stalls
Symptom relief TerminatedThis study aimed to see if a retinal (eye) biomarker could predict how well people with early schizophrenia respond to sodium nitroprusside, an anti-inflammatory drug. It planned to enroll people diagnosed within the last 5 years, but was terminated early after only 1 participant…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated May 26, 2026 03:58 UTC
-
Digital tool for psychosis care: what helps or hinders its use?
Knowledge-focused TerminatedThis study aimed to understand what helps or gets in the way of using Horyzons, a digital platform with therapy and social features, in clinics for young people with early psychosis. Researchers recruited providers and clients from five clinics in North Carolina and gathered feed…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Heart risk check for mental health meds
Knowledge-focused TerminatedThis study looked at heart disease risk in 48 adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were taking antipsychotic medications. Researchers measured cholesterol levels and heart electrical activity to understand how these drugs might affect the h…
Matched conditions: SCHIZOAFFECTIVE DISORDER
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC